The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
This presentation focuses on polypharmacy in long-term care (LTC) and zooms out to take a meta view of polypharmacy on patient populations in LTC settings, LTC staff, regulatory implications in skilled nursing, and how reducing polypharmacy positively impacts these same areas. This will help advanced practice nurses practicing in this setting to understand the broader implications of prescribing practices. The presentation includes realworld examples, as well as a case study of a LTC resident and how these efforts impacted her. The end of the presentation will include practical tips on how to reduce polypharmacy across populations as part of the interdisciplinary team in a targeted way.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 9/30/2025.
Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your nursing continuing professional development (NCPD) certificate at any time after you complete the evaluation.
Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):
Planning Committee Disclosures: There are no disclosures to declare.
Speaker Disclosures: There are no disclosures to declare.
Commercial Support: No commercial support declared.
Accreditation Statement: This educational activity is jointly provided by Anthony J. Jannetti, Inc. (AJJ) and the Gerontological Advanced Practice Nurses Association (GAPNA).
Anthony J Jannetti, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
Anthony J. Jannetti, Inc. is a provider approved by the California Board of Registered Nursing, Provider Number CEP5387.
Learning Outcome: After completing this learning activity, participants will report the ability to discuss the implications of polypharmacy and deprescribing efforts.